Heart rate

Aktiia Secures CHF 27 Million (USD 30M) in Funding from Khosla Ventures and Others, Welcomes Daniel Graf as New President and Board Member to Accelerate Innovation in Hypertension Management

Retrieved on: 
Tuesday, February 27, 2024

In conjunction with this funding, Aktiia is delighted to welcome Daniel Graf as its new President and Board Member.

Key Points: 
  • In conjunction with this funding, Aktiia is delighted to welcome Daniel Graf as its new President and Board Member.
  • Daniel, a seasoned technology executive with a distinguished career at companies like Uber and Google, brings a wealth of experience in entrepreneurship, product innovation, and scaling businesses.
  • His leadership will be instrumental in guiding Aktiia's strategic direction and expansion as the company continues to pioneer advancements in hypertension management.
  • "We are proud to have Daniel join our board and executive team," said Mattia Bertschi, CEO of Aktiia.

Latest EnsoData FDA 510(k) Clearance Enables AI-Powered Sleep Diagnosis Using Pulse Oximetry Devices

Retrieved on: 
Monday, February 26, 2024

MADISON, Wis., Feb. 26, 2024 /PRNewswire/ -- EnsoData, a pioneer in healthcare AI, achieved FDA 510(k) clearance for groundbreaking technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry (pulse ox) devices. Powered by EnsoSleep PPG scoring, widely available and wearable pulse ox technology can be deployed for a high quality, accessible, and cost-effective approach to diagnosing sleep disorders, including sleep apnea.

Key Points: 
  • New EnsoData Diagnostic AI Advances Mission to Make Healthcare More Accessible, Affordable for Patients
    MADISON, Wis., Feb. 26, 2024 /PRNewswire/ -- EnsoData , a pioneer in healthcare AI, achieved FDA 510(k) clearance for groundbreaking technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry (pulse ox) devices.
  • "Expanding EnsoData's capability to collect and analyze PPG signals from simple, wearable pulse ox devices will accelerate the identification, diagnosis and treatment of sleep disordered breathing events, including sleep apnea," said Justin Mortara, President and CEO of EnsoData.
  • Compared to earlier generations of sleep diagnostic equipment, pulse ox devices are smaller and less expensive.
  • "This FDA clearance marks a pivotal moment in sleep diagnostics, and also long-term therapy monitoring and management, where enhanced accessibility and affordability can create a new normal in sleep care."

Global Digital Health Market to Reach $815.35 Billion by 2030 Owing To the Rapid Increase in Demand for Telehealth and Telemedicine | Says Coherent Market Insights

Retrieved on: 
Monday, February 26, 2024

One of the key trends in the digital health market is the integration of artificial intelligence (AI) in healthcare technologies.

Key Points: 
  • One of the key trends in the digital health market is the integration of artificial intelligence (AI) in healthcare technologies.
  • Another trend in the digital health market is the increasing focus on data security and privacy.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1909
    Telehealthcare technology is expected to hold a dominant position in the digital health market.
  • Key players operating in the Digital Health Market include Teladoc Health, American Well Corporation, Doctor on Demand, and MDLIVE.

Global Digital Health Market to Reach $815.35 Billion by 2030 Owing To the Rapid Increase in Demand for Telehealth and Telemedicine | Says Coherent Market Insights

Retrieved on: 
Monday, February 26, 2024

One of the key trends in the digital health market is the integration of artificial intelligence (AI) in healthcare technologies.

Key Points: 
  • One of the key trends in the digital health market is the integration of artificial intelligence (AI) in healthcare technologies.
  • Another trend in the digital health market is the increasing focus on data security and privacy.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1909
    Telehealthcare technology is expected to hold a dominant position in the digital health market.
  • Key players operating in the Digital Health Market include Teladoc Health, American Well Corporation, Doctor on Demand, and MDLIVE.

Light up your run with the Garmin Forerunner 165 Series, easy-to-use GPS running smartwatches with vibrant AMOLED displays

Retrieved on: 
Tuesday, February 20, 2024

OLATHE, Kan., Feb. 20, 2024 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the Forerunner® 165 Series, affordable GPS running smartwatches that help athletes of all skill levels meet their goals with personalized adaptive training plans plus popular health and fitness metrics—all on a bright AMOLED display. Available in two models, Forerunner 165 and Forerunner 165 Music, the latest additions to Garmin's pace-setting lineup of running smartwatches boast easy-to-read full-color displays, responsive touchscreens and a traditional 5-button design. With fast and easy access to everyday health features, advanced training metrics, recovery insights, smart notifications and more, runners can track their progress without sacrificing battery life; both models get up to 11 days of battery life in smartwatch mode and up to 19 hours in GPS mode.

Key Points: 
  • Available in two models, Forerunner 165 and Forerunner 165 Music , the latest additions to Garmin's pace-setting lineup of running smartwatches boast easy-to-read full-color displays, responsive touchscreens and a traditional 5-button design.
  • AMOLED Display: View training stats, recovery insights, smart notifications and more on a vibrant, 1.2-inch AMOLED display.
  • VIDEO: See how the Forerunner 165 Series can help you light up your running goals.
  • Available now, the Forerunner 165 has a suggested retail price of $249.99 while the Forerunner 165 Music is $299.99.

St. Elizabeth Healthcare First in Kentucky to Implant New Device To Treat Abnormal Heart Rhythm

Retrieved on: 
Friday, February 16, 2024

J. Christian Hays, MD , Director of Cardiac Electrophysiology at St. Elizabeth Healthcare, performed the procedure on January 12, 2024.

Key Points: 
  • J. Christian Hays, MD , Director of Cardiac Electrophysiology at St. Elizabeth Healthcare, performed the procedure on January 12, 2024.
  • Implantable cardioverter-defibrillators (ICDs) are devices doctors implant in the upper chest to treat arrhythmias.
  • If it detects an irregular heart rhythm or one that's too fast, the device sends an electrical signal through the lead to the heart.
  • Learn more about cardiology services offered at St. Elizabeth Healthcare or contact us at 859-331-3353.

Finding joy in the little things really can benefit your wellbeing – a scientist explains

Retrieved on: 
Wednesday, February 14, 2024

This piece of folk advice has been around for aeons, and is one that many of us try to live by.

Key Points: 
  • This piece of folk advice has been around for aeons, and is one that many of us try to live by.
  • But is there actually any real benefit to this practice?
  • According to research, yes, there is indeed some benefit to savouring fleeting moments of joy – also known as “micro-joys”.
  • Some studies suggest a magic number: five positive emotions to one negative emotion for optimal wellbeing.


Better self-regulation has a ripple effect on various aspects of our lives – such as preventing addiction or self-defeating behaviours (including procrastination, blame and perfectionism). Making time to do even just small, personal tasks such as making lists, tracking daily budgets and even working on your posture each day can help strengthen your self-regulation and ward off against failures.

Finding micro-joy

  • First, research suggests that some people’s genetics may make them more likely to benefit from micro-joys than others.
  • Studies show that people who are highly sensitive to their environment may disproportionately benefit from engaging in positive activities, such as micro-joys.
  • Here are a few ways you can practice finding joy in the little things:


Change your routine. Trying adding a 10-minute burst of joy into your normal morning, afternoon or evening routine which can give you a moment of delight to look forward to. For example, savouring a cup of tea.
Look out for moments of humour. Humour can be a great way to find joy each day. But if you find it hard to see joy in your day, try to imagine how your favourite comedian might hilariously interpret the events of your day.
Be spontaneous. Challenge your routine by introducing spontaneity into your day – even if you’re typically a meticulous planner. Embrace the unexpected – even if just for a rejuvenating, five-minute break to call a friend you haven’t spoken with in a while.
Pursue moments of connection and shared laughter with strangers, neighbour or acquaintances. Strengthening these social bonds can add a joy to your day.
Pause and appreciate. Taking regular breaks to savour the simple act of being alive throughout your day can bring a renewed sense of mindfulness and gratitude that result in joy. For example, listen to the birds singing, or allow yourself to laugh out loud when someone says something funny.
Engaging in small moments of joy daily holds the potential to elevate both short- and long-term wellbeing for many – though for some the impact of these activities will be more subtle than for others.
Jolanta Burke does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Blue Marble Health and Allergy & Asthma Network Announce SBIR Award to Pilot Innovative BREATHE Virtual Asthma Coaching Platform

Retrieved on: 
Tuesday, February 13, 2024

NIH awarded the SBIR funding to Blue Marble Health to develop the BREATHE (BRinging Asthma Education, Assessments, and Exercise To Everyone) virtual self-management platform.

Key Points: 
  • NIH awarded the SBIR funding to Blue Marble Health to develop the BREATHE (BRinging Asthma Education, Assessments, and Exercise To Everyone) virtual self-management platform.
  • The Blue Marble Health Platform is designed to support Allergy & Asthma Network's 6-week asthma self-management program with 1-on-1 certified asthma educators.
  • The Blue Marble Health Asthma Self-Management Platform serves as the virtual asthma coaching platform for the Trusted Messengers Community Outreach Program, the signature health equity program of Allergy & Asthma Network.
  • The Blue Marble Health's Asthma Self-Management Platform is the first commercially available digital asthma self-management platform available for people in under-resourced communities and those experiencing long-term health disparities.

HIMALAYA TECHNOLOGIES ADDS FORTUNE 100 TELECOMMUNICATIONS EXECUTIVE TO ADVISORY BOARD; COMPANY TARGETING VAST TELEHEALTH MARKET

Retrieved on: 
Tuesday, February 13, 2024

Said Vik Grover, CEO: “I am thrilled Mr. Nahabedian has joined Himalaya to help us build a significantly larger organization.

Key Points: 
  • Said Vik Grover, CEO: “I am thrilled Mr. Nahabedian has joined Himalaya to help us build a significantly larger organization.
  • His vision, expertise, and network of contacts is a competitive advantage for our plans for the telehealth market.
  • With his help, Himalaya intends to capture meaningful share of the segment’s multi-billion dollar market.
  • I am very excited to bring HMLA into the telehealth market and create significant value for our shareholders.”

Study Shows Nasal Powder Epinephrine Provides Superior Stability to EpiPens

Retrieved on: 
Monday, February 12, 2024

MILWAUKEE, Feb. 12, 2024 /PRNewswire-PRWeb/ -- Nasal powder formulations of epinephrine demonstrated superior stability and comparable plasma exposure to EpiPens according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting.

Key Points: 
  • MILWAUKEE, Feb. 12, 2024 /PRNewswire-PRWeb/ -- Nasal powder formulations of epinephrine demonstrated superior stability and comparable plasma exposure to EpiPens according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting.
  • In the study, proprietary amorphous powder formulations were developed using spray-drying, and the stability of those formulations was evaluated under accelerated conditions and compared to the EpiPen.
  • Powder formulations of epinephrine were rapidly absorbed with comparable plasma levels to EpiPens reached within about 5-10 minutes.
  • The findings suggest nasal powder formulations of epinephrine demonstrated superior stability and comparable plasma exposure to EpiPens, making them an effective treatment option for patients.